Find Academic Supervisors

Professor Daniel Rueckert is a leading academic in Artificial Intelligence and Medical Imaging, holding dual positions at Imperial College London (as Professor of Visual Information Processing) and Technical University of Munich (Alexander von Humboldt Professor for AI in Medicine and Healthcare). He obtained his MSc from Technical University Berlin (1993) and PhD from Imperial College London (1997), followed by postdoctoral work at King’s College London. At Imperial, he led the Department of Computing (2016–2020) and founded the Biomedical Image Analysis group. His research focuses on AI-driven medical image analysis, including algorithms for image reconstruction, registration, and clinical decision support. His research interests span AI applications in healthcare, machine learning for medical imaging, and computational methods for clinical diagnostics. Notable contributions include over 500 publications and 60+ PhD graduates, with key works in federated learning, cardiac motion analysis, and biomarker development. Awards include the Leibniz Prize (2025), Royal Academy of Engineering Fellowship (2015), and multiple ERC grants. He leads the BioMedIA research group and is an editorial board member of Medical Image Analysis . Recent publications highlight advancements in AI-driven medical imaging, such as secure federated learning frameworks and deep learning models for disease prediction. His work bridges academic and industrial sectors through initiatives like IXICO, an Imperial spin-out. Current affiliations include roles at both Imperial and TUM, emphasizing interdisciplinary collaboration in healthcare technology. Advising and grants: Supervised over 60 PhD students and 40 post-docs. Secured grants including ERC Synergy (2013) and ERC Advanced (2020). Active in labs focused on biomedical image computing and AI in healthcare systems. Collaborative efforts include the BioMedIA group and TUM’s AI initiatives. Labs/teams: Leads the Biomedical Image Analysis group at Imperial and the TUM AI in Medicine team. Collaborates extensively on projects like cardiac imaging analysis and federated learning for healthcare.

• Artificial Intelligence
• Machine Learning
• Medical Imaging
• +3 more

Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.

• Nuclear Magnetic Resonance (NMR)
• In vivo imaging
• MRI pulse sequence development
• +7 more

Colin J Akerman is Professor of Neuroscience and Group Leader in the Department of Pharmacology at the University of Oxford, concurrently serving as Corange Fellow and Medical Tutor at Corpus Christi College. His research investigates fundamental mechanisms of synaptic circuit formation and plasticity, with direct implications for epilepsy, dementia, and schizophrenia through multidisciplinary approaches integrating electrophysiology, optical imaging, and computational modeling. His primary research interests encompass Synaptic Plasticity, Neural Circuit Formation, and Excitatory-Inhibitory Balance, with specific focus on neuronal progenitor influences on connectivity, chloride dynamics in inhibitory transmission, and learning mechanisms in disease contexts. The lab employs custom-built equipment and molecular tools to probe synaptic function across in vivo , in vitro , and in silico platforms, emphasizing how activity-dependent processes shape neural networks during development and disease. Recent publications (2023-2025) reveal strong thematic convergence on intracellular chloride regulation in sleep-wake cycles, cortical circuit assembly from embryonic progenitors, and innovative optical tools for neural monitoring. This work bridges molecular neuroscience with systems-level understanding of synaptic plasticity, particularly regarding ionic mechanisms in epilepsy and sleep homeostasis. No scientific awards or fellowships are explicitly documented in the source materials. Professor Akerman currently mentors four PhD students (Vourvoukelis, Selfe, Wang, Gemayel) and multiple postdoctoral researchers, having previously trained scientists now leading independent groups in Toronto, Edinburgh, Cape Town, Oxford, and London. His research is funded by the European Research Council, Innovative Medicines Initiative, and Wellcome Trust, supporting investigations into synaptic mechanisms underlying neurological disorders. The Akerman Group, established in 2008, operates as an integrative neuroscience hub within Oxford's Pharmacology Department. The 10-member team combines expertise in patch-clamp electrophysiology, optogenetics, multiphoton imaging, and computational modeling, with current projects spanning neuronal progenitor biology, inhibitory synaptic plasticity, and learning rule implementation in neural networks. The lab emphasizes technical innovation, regularly developing custom instrumentation and molecular tools for neural observation and manipulation.

• Neuroscience
• Synaptic Plasticity
• Neural Circuit Formation
• +4 more

Sharon Abrahams is a Professor of Neuropsychology and holds a Personal Chair at the University of Edinburgh's School of Philosophy, Psychology and Language Sciences. She leads research in clinical and experimental neuropsychology, focusing on neurodegenerative diseases like motor neurone disease/ALS and frontotemporal dementia. Her work integrates neuroimaging, cognitive assessment, and clinical intervention. She is affiliated with the Euan MacDonald Centre for Motor Neurone Disease, the Centre for Clinical Brain Sciences, and Edinburgh Neuroscience. Current PhD students include Monica de Icaza Valenzuela, Debbie Gray, and Caroline McHutchison. Abrahams has secured over 17 research grants since 2008, including projects on cognitive screening in MND, apathy impact, and the ECAS tool. Her research emphasizes cognitive and behavioral changes in ALS, with a focus on early detection, staging, and patient quality of life. Notable contributions include the Edinburgh Cognitive and Behavioural ALS Screen (ECAS), validated across multiple languages and populations.

• Clinical Neuropsychology
• Neuroimaging
• Neurodegenerative Diseases
• +4 more

Professor Emma Moore is a leading sociolinguist at the School of English, University of Sheffield . Specializing in the social dimensions of language, her work integrates methodologies from anthropology and sociology to investigate how linguistic variation constructs identity and social affiliations. Research focus: Sociolinguistic style, dialect contact, youth language, identity negotiation, and community-based fieldwork Key projects: Adolescence and grammar (1999-), Isles of Scilly dialect (2008-), language and inequality (2014-), language perception software (2016-) Educational background : PhD in Sociolinguistics, University of Manchester Stanford University (USA) during PhD research Research trends across her 2021-2025 publications reveal interdisciplinary exploration of: Socio-syntactic variation Clinical linguistics (2025 MDS-UPDRS studies) Digital discourse post-pandemic Indexicality and cognitive representations Dialect contact in insular communities Educational policy implications Scientific recognition : British Academy Mid-Career Fellow (2019-2020) Elected Fellow, Royal Anthropological Institute (2014) AHRC/BA funded research projects (1999-2015) Research group leadership : Mentored 9 PhD students (2004-2024) and supervised 3 undergraduate SURE projects, including analyses of: Gender in rap performance Language style and workplace inequality Oral history digitization Professional contributions : Editorial Board: Language in Society (2015-), Gender and Language (2011-2017) External Examiner: Lancaster University MA in English Language (2013-2017) Collaborative software development for dialect perception testing

• Sociolinguistics
• Syntax
• Language Variation
• +12 more

Ali Abbas is a Senior Researcher and Methods Fellow at the MRC Epidemiology Unit within the University of Cambridge's School of Clinical Medicine. His academic background includes a PhD in Computer Science from Manchester Metropolitan University, an MSc in Media Informatics from RWTH Aachen University, and a BS in Computer Science from Mohammad Ali Jinnah University. With over two decades of research experience, he specializes in data-driven approaches including exploratory analysis, statistical modelling, and interactive visualization. His core research focuses on developing environmentally sustainable transport systems with positive public health outcomes, particularly through: Agent-based modeling of transport behaviors Cycling infrastructure and active travel interventions Health impact assessment of urban mobility policies Spatial analysis using GIS technologies Complex systems approaches to public health He leads several major research initiatives including the JIBE project (integrating transport and built environment models), GLASST (global health impact assessment), TIGTHAT (integrated global transport-health tool), National Propensity to Cycle Tool, and Impacts of Cycling Tool. His publication portfolio demonstrates consistent focus on transport-health interactions, physical activity epidemiology, and urban health modelling, with recent work emphasizing policy applications and global scalability. As an advocate for open science, he maintains active GitHub repositories of his computational models. He additionally manages junior researchers and contributes to training initiatives within his unit.

• Public Health Modelling
• Transport Planning
• Active Travel
• +4 more

Zhongying Deng is a Research Fellow in the Department of Applied Mathematics and Theoretical Physics (DAMTP) at the University of Cambridge, affiliated with the Cambridge Image Analysis research group. His work focuses on advancing medical imaging technologies and computer vision through deep learning and domain adaptation techniques. Key contributions include developing benchmark datasets like TrafficCAM and TrafficMOT for traffic analysis, A-Eval for abdominal organ segmentation, and foundational models for medical AI such as GMAI-VL. His research bridges theoretical advancements in neural networks and practical applications in healthcare and transportation. His research interests span image segmentation, domain adaptation, neural network architectures, and multimodal data integration. Notable projects include FCN+ for enhanced convolutional networks and Brain Foundation Models for neurodegenerative disease analysis. Deng collaborates extensively on interdisciplinary projects, combining mathematical modeling with computational tools to address real-world challenges in medical diagnosis and autonomous systems. Publications emphasize scalable medical image analysis frameworks (e.g., STU-Net, Sa-med2d-20m) and robust domain adaptation methods for cross-dataset performance. His datasets and models are widely recognized for enabling reproducible research and advancing state-of-the-art performance in critical areas like MRI reconstruction and multi-organ segmentation.

• Medical Imaging
• Computer Vision
• Deep Learning
• +3 more

Professor Richard Wade-Martins is a leading academic in University of Oxford 's Department of Physiology, Anatomy and Genetics . He directs the Molecular Neurodegeneration Research Laboratory and the Oxford Parkinson’s Disease Centre (OPDC). With degrees from Cambridge (MA) and Oxford (DPhil), he has held prestigious fellowships including Wellcome Trust Research Career Development Fellowship and NIH reviewer roles. His research targets molecular mechanisms in Parkinson’s and Alzheimer’s diseases through iPSC models , transgenic mice , and lysosomal function studies . He pioneered work on SNCA , MAPT , and LRRK2 gene pathways. Current projects focus on gene therapy and mitochondrial dysfunction in neurodegeneration. Key publications (2019–2025) reveal trends in single-cell transcriptomics , calcium channel inhibition , and TFEB/TFE3 lysosome modulation . His awards include Wellcome Trust Fellowships and advisory roles for Parkinson's UK , Alzheimer's Research UK , and EU consortia like StemBANCC and EFACTS . He leads the UK Dementia Platform iPSC Initiative and serves on international boards in Luxembourg and Canada.

• Neurodegenerative Diseases
• Molecular Neuroscience
• Stem Cell Research
• +3 more

Mark Jenkinson is a Professor of NeuroImaging at the University of Oxford's Nuffield Department of Clinical Neurosciences and also holds positions at the University of Adelaide's Australian Institute for Machine Learning and the South Australian Health and Medical Research Institute (SAHMRI). He heads the Structural Modelling and Analysis Group at the FMRIB Centre, where his research focuses on multimodal population modeling and structural brain segmentation. Education: DPhil in Robotics Research (University of Oxford, 1999) BSc (Hons I) in Mathematical Physics (University of Adelaide, 1994) BE (Hons I) in Electrical and Electronic Engineering (University of Adelaide, 1993) Professor Jenkinson's research spans two major themes: multimodal modeling of populations to describe disease processes and apply to individual patient diagnoses, and structural segmentation and analysis of brain anatomy and pathology, particularly focusing on sub-cortical structures and lesions. His work integrates advanced computational methods with neuroimaging to develop tools for understanding neurological disorders. As the developer of key components of the FMRIB Software Library (FSL), he has significantly contributed to standard neuroimaging analysis pipelines used worldwide. His recent publications demonstrate a strong focus on deep learning applications in neuroimaging, uncertainty quantification in medical AI, and advanced segmentation techniques. There's a clear trend toward developing more robust, anatomically plausible models that preserve topological structures while improving diagnostic capabilities for conditions like multiple sclerosis, Huntington's, and Parkinson's diseases. Scientific Awards: Highly Cited Researcher (Clarivate Analytics 2018-2021, Thomson Reuters 2014-2016) ISMRM Outstanding Teacher Award (2009, 2014) Teaching Excellence Award, University of Oxford (2012) David Phillips Fellowship from BBSRC (2005-2010) Professor Jenkinson has supervised over 25 doctoral students whose work spans brain segmentation, connectivity analysis, and clinical applications of neuroimaging. His research is supported by significant grants including the Medical Research Future Fund (AU$2m), Wellcome Trust Centre for Integrative Neuroimaging (£11m), and NIH Human Connectome Project (US$30m), reflecting the high impact and translational potential of his work. As head of the Structural Modelling and Analysis Group at FMRIB, Jenkinson leads a team developing the FSL (FMRIB Software Library), one of the most widely used neuroimaging analysis packages globally. His group collaborates extensively with clinical researchers on applications ranging from multiple sclerosis to traumatic brain injury, translating computational advances into clinical practice.

• Neuroimaging
• Structural brain segmentation
• Multimodal population modeling
• +6 more

Zsofia Zavecz is a Research Associate at the University of Cambridge Department of Psychology. Her work focuses on the neurophysiological mechanisms underlying sleep and memory consolidation, with particular emphasis on electrophysiological correlates of lucid dreaming and sleep-dependent learning. Research highlights include: Investigation of EEG functional connectivity during statistical learning Study of transcranial stimulation effects on probabilistic learning Analysis of sleep restriction impacts on hormonal regulation Exploration of cognitive reserve mechanisms in sleep disorders Her neuroscientific investigations span procedural memory systems, neural oscillations, and cross-population studies in both healthy individuals and pediatric sleep-disordered breathing patients.

• Cognitive Neuroscience
• Sleep Research
• Electrophysiology
• +3 more

Colin Cooper is a Professor of Cancer Genetics at the Norwich Medical School, University of East Anglia. He is also a member of the Metabolic Health and Cancer Studies research groups. His work focuses on genomic evolution, tumor microbiome dynamics, and biomarker development for prostate cancer and musculoskeletal health. Cooper’s recent research explores the interplay between cancer genetics and microbial communities, emphasizing their role in prognosis and treatment outcomes. He investigates clonal evolution in tumors, mutational signatures, and non-invasive diagnostic tools like urinary extracellular vesicles. His collaborations span genomics, microbiology, and clinical applications. 2025: Causes of evolutionary divergence in prostate cancer (Genomics, Precision Medicine) 2024: Applications of urinary extracellular vesicles... (Biomarker Development, Liquid Biopsy) 2023: Caution regarding pan-cancer microbial structure (Methodological Considerations, Microbiome Analysis) In 2022, Cooper received the European Urology Oncology SoMe Award for his contributions. His work is frequently cited and has been featured in media outlets globally, highlighting his impact on cancer and aging research.

• Cancer Genetics
• Prostate Cancer
• Genomic Evolution
• +5 more

Sarah Lummis is a Professor in the Department of Biochemistry at the University of Cambridge. Her research focuses on understanding the structure-function relationships of Cys-loop ligand-gated ion channels (pLGICs), which are critical for neurotransmission and targets for pharmaceuticals. Her work addresses how structural features of these receptors influence their function and drug interactions. Research interests include ion channel biology, molecular pharmacology, and structural biology. Key publications investigate residues affecting receptor activity in 5-HT3 receptors, glycine receptors, and the prokaryotic channel ELIC. Her studies contribute to drug development for neurological disorders like epilepsy and Alzheimer's disease. Contact: sl120sec@bioc.cam.ac.uk | Group accepts interns, students, and researchers. Located at the Hopkins Building, Downing Site, Cambridge.

• Neuroscience
• Biochemistry
• Structural Biology
• +3 more

Professor Gabriele Kaminski Schierle is affiliated with the Department of Chemical Engineering and Biotechnology at the University of Cambridge. She is a Senior Fellow of the Higher Education Academy and collaborates with other researchers, including Professor Clemens Kaminski, Professor J. Axel Zeitler, and Professor Sabine Bahn. Her research focuses on neurodegenerative diseases and advanced imaging technologies. Her work spans Alzheimer's, Parkinson's, and Huntington's diseases , utilizing brain organoids, fluorescence lifetime imaging, and machine learning . She leads the Molecular Neuroscience Group and contributes to the EPSRC Centre for Doctoral Training in Sensor Technologies and Applications. Email: gsk20@cam.ac.uk Contact: +44 (0)1233 766549

• Alzheimer's disease
• Parkinson's disease
• Huntington's disease
• +6 more

Dr. Arpan Mehta is an Independent Investigator at the MRC Protein Phosphorylation and Ubiquitylation Unit, specializing in neurodegenerative diseases with a focus on Amyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia. He was awarded the 51st Sir John Halliday Croom Medal and Lectureship by the Royal College of Physicians of Edinburgh for his groundbreaking research on ALS mechanisms. His work explores the role of kinases and genetic mutations (e.g., C9ORF72) in neurodegeneration, alongside mitochondrial dysfunction and clinical trial methodologies. Research interests include molecular mechanisms underlying ALS, neuroimmunology, and improving clinical trial designs for neurodegenerative diseases. Dr. Mehta advocates for rigorous research standards, addressing reproducibility challenges, and optimizing therapeutic approaches. His recent studies investigate mitochondrial bioenergetic deficits in ALS motor neurons and the impact of cerebrospinal fluid (CSF) toxicity. Awards: Sir John Halliday Croom Medal and Lectureship (2025) His publications span clinical neurology, neurodegenerative disease mechanisms, and ethical aspects of medical practice. Dr. Mehta emphasizes interdisciplinary collaboration to advance understanding of ALS pathogenesis and translational therapies.

• Neurodegenerative Diseases
• Amyotrophic Lateral Sclerosis (ALS)
• Molecular Neuroscience
• +3 more

Yan Liu is a Senior Lecturer in Glycosciences at Imperial College's Department of Metabolism, Digestion and Reproduction (Faculty of Medicine). She leads the Wellcome Trust-funded Carbohydrate Microarray Facility and co-leads the GlycoTWINNG Network. Her research focuses on glycan-mediated interactions in host-microbiota interfaces, with applications in infectious diseases and reproductive health. She holds a B.Sc. from Peking University and a Ph.D. from the University of Bristol, followed by postdoctoral work at Imperial College under Professor Ten Feizi FRS. Her academic journey includes roles as a Microarray Project Leader and co-investigator in the March of Dimes European Preterm Birth Research Centre. She is PI of a £1.34M Wellcome Trust grant maintaining Imperial's Carbohydrate Microarray Facility, advancing glycan array technologies. Research interests span microbiology, immunology, and biomolecular chemistry, with a focus on glycobiology. Key contributions include defining glycan interactions in pathogen-host systems (e.g., Candida albicans, adenoviruses), developing glycan probes, and analyzing vaginal microbiota impacts on preterm birth. Grants and collaborations include EPSRC Translational funding and the UK 'FluTrialMAP' consortium. Labs affiliations include the Glycosciences Laboratory and Imperial's Institute of Infection.

• Microbiology
• Immunology
• Medicinal Chemistry
• +4 more